Oppenheimer analyst Edward Yang raised the firm’s price target on Lam Research (LRCX) to $330 from $265 and keeps an Outperform rating on the shares. The firm notes Lam’s Q3 results beat elevated expectations, driven by CSBG and China, but the real standout was a muscular Q4 outlook, showing that the pace of raises is still accelerating despite cleanroom constraints.
Meet Samuel – Your Personal Investing Prophet
LRCU: an alternative to margin or options on LRCXPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRCX:
- Lam Research price target raised to $350 from $330 at B. Riley
- Lam Research price target raised to $310 from $290 at RBC Capital
- Lam Research price target raised to $330 from $285 at BofA
- Lam Research price target raised to $340 from $290 at TD Cowen
- Lam Research price target raised to $325 from $300 at Stifel
